Active not recruiting × INDUSTRY × Observational × Clear all CREATE
Active not recruiting
712 enrolled
DADOX
Active not recruiting
100 enrolled
JPMS-DTC
Active not recruiting
453 enrolled
DAROL
Active not recruiting
805 enrolled
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
Active not recruiting
757 enrolled
PERFORM
Active not recruiting
1,407 enrolled
ENTIRETY
Active not recruiting
50 enrolled
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
Active not recruiting
1,200 enrolled
ArtemisPRO
Active not recruiting
504 enrolled
RE-ENGAGE
Active not recruiting
700 enrolled
UK-EnBiRiM
Active not recruiting
50 enrolled
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
Active not recruiting
50 enrolled
OPTYX
Active not recruiting
999 enrolled
AUS-PREDICT
Active not recruiting
1,500 enrolled
SHIELD
Active not recruiting
12,000 enrolled
METAGIO
Active not recruiting
208 enrolled
ROAD
Active not recruiting
1,600 enrolled
Polaris
Active not recruiting
10,000 enrolled
ROSE
Active not recruiting
450 enrolled
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Active not recruiting
29 enrolled
PARFENOPA
Active not recruiting
329 enrolled
CABOCARE
Active not recruiting
224 enrolled
REPLICA
Active not recruiting
150 enrolled
Safety and Efficacy of Xalkori ROS1
Active not recruiting
97 enrolled
OVAmiARN
Active not recruiting
746 enrolled
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Active not recruiting
10,000 enrolled
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
Active not recruiting
2,907 enrolled
MUST
Active not recruiting
250 enrolled
REACH
Active not recruiting
250 enrolled
REAL-LU
Active not recruiting
164 enrolled
DELFI-L201
Active not recruiting
11,935 enrolled
MiDura
Active not recruiting
328 enrolled
ACROBAT
Active not recruiting
307 enrolled
NIS durvalumab
Active not recruiting
250 enrolled
ACT-MBC
Active not recruiting
65 enrolled
RosaLEE
Active not recruiting
1,019 enrolled
MG Cohort
Active not recruiting
1,199 enrolled
OPAL
Active not recruiting
537 enrolled
Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions
Active not recruiting
1,178 enrolled
VICTORIE
Active not recruiting
1 enrolled
PASS of Paediatric Patients Initiating Selumetinib
Active not recruiting
124 enrolled
PICAROS
Active not recruiting
192 enrolled
Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
Active not recruiting
44 enrolled
NAOS
Active not recruiting
350 enrolled
Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve
Active not recruiting
160 enrolled
Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations
Active not recruiting
1,500 enrolled
ARSENAL
Active not recruiting
254 enrolled
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Active not recruiting
360 enrolled
Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer
Active not recruiting
760 enrolled
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Active not recruiting
400 enrolled